Dr. Yu Baofa n'itsinda ryaturutse muri Amerika basohoye inkuru mu kinyamakuru cya Gastroenterology Research and Practice 

Icyari kigamijwe muri ubu bushakashatsi kwari ugusuzuma akamaro k’amavuriro ya autoantibodies irwanya GNA11, MSLN, GNAS, CEBPA, MDM2, p16, Sui1, Calnuc, PTEN muri kanseri yandura (PC). Harimo urugero rwa serumu 33 z’abarwayi ba PC hamwe na 45 za serumu ziva mu igenzura risanzwe (NC), kandi ubwoko 9 bwa ​​autoantibodies bwagaragaye hakoreshejwe enzyme ifitanye isano na immunosorbent (ELISA). Suzuma ukoresheje ibipimo byinshi muburyo bwihariye cyangwa bwahujwe. Usibye kurwanya GNAS na anti calNUC, urwego rwizindi autoantibodies zose zari hejuru cyane ugereranije nabari mumatsinda asanzwe agenzura. Ugereranije nitsinda risanzwe rishinzwe kugenzura (4.9%), inshuro enye za autoantibodies, MSLN, p16, PTEN, na Sui1, ziyongereye cyane, kuri 75.8%, 66.7%, 30.3%, na 27.3%. Ubushobozi bwiyi autoantibodies yo gutandukanya agace kari munsi yumurongo wa ROC (AUC) kiva kuri 0.666 kugeza 0.884, hamwe na anti-p16 (AUC ya 0.884) na anti MSLN (AUC ya 0.857) yerekana imikorere ikomeye yo gusuzuma. Guhuza anti-MSLN na anti-p16 birashobora kunoza sensibilité yo gusuzuma.